From in-spa relief treatments to at-home consulting and a new all-in-one support supplement, were here for every step of your journey
Expanding Applications: Clinical trials are actively investigating the use of GLP-1 RAs for a wider range of conditions, including addiction, kidney disease, and neurodegenerative disorders, based on their broad physiological effects
STEP-8 (N=338) compared semaglutide 2.4 mg weekly to liraglutide 3.0 mg daily and found semaglutide produced 15.8% mean weight loss versus 6.4% for liraglutide at 68 weeks [10]
Consistency is key, so taking the supplement at the same time every day will help you achieve the best results
It is estimated that 8.4 million individuals are living with the disease worldwide, and this is expected to increase [1]
The optimal approach combines both modalities with an emphasis on strength training